About
Orizuru Therapeutics develops regenerative medicine therapies based on iPSC-derived islet cells and cardiomyocytes to restore cell function in type 1 diabetes and other conditions.
Explore Orizuru Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.